| Next 10 |
AMGN News and Press, Amgen Inc.
-
If a company is able to secure approval for a drug treatment and swipe market share from other drugs, the pharmaceutical industry can be extremely lucrative. This has certainly been the case for Johnson & Johnson 's (NYSE: JNJ) Stelara, which generated $9.1 billion in revenue fo...
-
Two new Breakout Stocks for Week 21 with better than 10% short-term upside potential, and two Dow 30 Picks. Average cumulative returns now up to +67.1% YTD. High frequency breakouts continue despite Negative Momentum Gauge® signals, with peak gains in 1 of 4 picks above 10%: SCSC...
-
Amgen can be a cornerstone in your portfolio due to its fortress financial strength, secular support, and strong profitability. At its present price levels, a dividend discount reveals a very asymmetric return profile with an upside near 40% but little downside. Its Accelerated St...
-
Amid the biotech bear market, there are companies that are trading on a deep bargain, yet you should be extremely careful before averaging down. Though I noticed the fundamental changes in Galapagos, I gave the company a year to turn around. Here, I presented to you three differen...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dividend stocks are a great way to buffer your portfolio against the uncertainty in the market, especially when thinking long-term. Bank of New York Mellon ( BK ) was originally owned by Alexander Hamilton and has ...
-
Larry Robbins and Mark Horowitz owned fund, Glenview Capital in its recent 13F filing disclosed newly acquired stakes in Valvoline (VVV) with 1.7M shares, Berkeley Lights (BLI) with 1.19M shares, Las Vegas Sands (LVS) with 1M shares, Meta Platforms (FB) with 0.08M shares. The fund exited posi...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As concerns over a looming recession grow, these are some blue-chip stocks to buy that could help decrease portfolio volatility. 3M ( MMM ): The recent purchase of LeanTec could improve long-term growth projectio...
-
Amgen Inc. (NASDAQ:AMGN) has been robust lately. The stock established a strong support at the oversold level of $233 in early May. The main catalyst for the gains in Amgen stock has been its quarterly results which came better than expected. As Amgen reported its first-quarter ...
-
Investors bailed out of tech and growth stocks even as tech insiders added more. Insider buying on the XLK ETF has surged to the highest in the last ten years. We discuss why the bottoming in tech and growth stocks could be forming. Subsequently, we believe the outperformance in growt...
-
AMGEN AND LANCE BASS PARTNER TO ENCOURAGE PEOPLE TO DO A 'DOUBLE TAKE' TO RECOGNIZE THE EARLY SIGNS OF PSORIATIC ARTHRITIS PR Newswire Campaign Drives Awareness of Potential Early Symptoms of Psoriatic Arthritis and Empowers People to Take Action THOUSAND OAK...
Stock Information
MENU
AMGN
AMGN Quote
AMGN Short
AMGN News
AMGN Articles
Get AMGN Alerts
News, Short Squeeze, Breakout and More Instantly...
-
If a company is able to secure approval for a drug treatment and swipe market share from other drugs, the pharmaceutical industry can be extremely lucrative. This has certainly been the case for Johnson & Johnson 's (NYSE: JNJ) Stelara, which generated $9.1 billion in revenue fo...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dividend stocks are a great way to buffer your portfolio against the uncertainty in the market, especially when thinking long-term. Bank of New York Mellon ( BK ) was originally owned by Alexander Hamilton and has ...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As concerns over a looming recession grow, these are some blue-chip stocks to buy that could help decrease portfolio volatility. 3M ( MMM ): The recent purchase of LeanTec could improve long-term growth projectio...